Our objectives were to analyze the presence of methylation of the less-studied RASSF2 gene in breast cancer subtypes, along with the well-known gene RASSF1, and to evaluate the prognostic role of these alterations in patients. This evidence concerns the gene RASSF2 and breast cancer.